Product logins

Find logins to all Clarivate products below.


Orthopedic Biomaterials | Europe | 2016 | Market Analysis

New product releases in the BGS market as well as favorable demographics will continue to drive moderate procedure growth and offset downward pricing pressures in the orthopedic biomaterial market. Nevertheless, economic difficulties, negative publicity for some products, as well as variable reimbursement will remain limiting factors in this space.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for orthopedic biomaterials in Europe across a 10-year period.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Trauma Devices – Market Insights – Latin America
The Latin American trauma device market is positioned for strong growth, driven by the rapid expansion of highvolume product segments, a growing aging population, and increasingly favorable…
Report
Infusion Pumps – Market Insights – Europe
The European infusion pump demand will be underpinned by aging populations and rising chronic disease, while accelerating adoption of closed-loop, EHR-integrated smart pumps and growing demand of…
Report
Laparoscopic Devices – Market Insights – Europe
Laparoscopic procedure volumes in Europe will grow only modestly through 2034, with notable variation across procedure types. Bariatric and colorectal laparoscopic surgeries are expected to…